SCHEMBL20989014

SCHEMBL20989014

c1ccc2c(c1)ccc1ccc(-n3c4ccccc4c4ccc5c6ccc7ccccc7c6oc5c43)cc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.38
CYP1B1 Q16678 7/20 0.36
CYP1A1 P04798 6/20 0.36
PRKDC P78527 6/20 0.36
ALDH1A1 P00352 4/20 0.36
CYP1A2 P05177 4/20 0.36
HSD17B10 Q99714 3/20 0.36
KDM4E B2RXH2 3/20 0.36
HPGD P15428 3/20 0.36
MAPT P10636 3/20 0.36
HTT P42858 2/20 0.36
ALOX15 P16050 1/20 0.36
PDE5A O76074 1/20 0.36
TP53 P04637 1/20 0.36
ABCB1 P08183 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP19A1 P11511 1/20 0.36
CYP2C9 P11712 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18086171 0.90 TDP1 (0.35) CYP1B1ALDH1A1CYP1A2HSD17B10KDM4E
SCHEMBL17690968 0.87 KDM4E (0.37) CYP1B1CYP1A1ALDH1A1KDM4EHPGD
SCHEMBL23733371 0.87 KDM4E (0.49) KMT2ACYP1B1CYP1A1PRKDCALDH1A1
SCHEMBL17690860 0.86 KDM4E (0.40) KMT2AALDH1A1HSD17B10KDM4ETSHR
SCHEMBL17990702 0.85 CYP1A1 (0.41) KMT2ACYP1B1CYP1A1PRKDCALDH1A1
SCHEMBL17245994 0.84 TDP1 (0.35) CYP1B1ALDH1A1CYP1A2HSD17B10KDM4E
SCHEMBL26809663 0.84 HPRT1 (0.47) CYP1B1ALDH1A1CYP1A2HSD17B10KDM4E
SCHEMBL17990613 0.83 CYP1A1 (0.42) KMT2ACYP1B1CYP1A1PRKDCALDH1A1
SCHEMBL17690890 0.83 TDP1 (0.37) CYP1B1CYP1A1ALDH1A1KDM4EHPGD
SCHEMBL17690884 0.82 L3MBTL1 (0.49) KMT2AALDH1A1HSD17B10KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11008280-B2 Compound for organic electric element, organic electric element using same, and electronic device comprising same organic electronic element DUK SAN NEOLUX CO., LTD. (KR) 2021-05-18 US disclosed
US-20190135730-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRONIC ELEMENT DUK SAN NEOLUX CO., LTD. (KR) 2019-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11008280-B2 Compound for organic electric element, organic electric element using same, and electronic device comprising same organic electronic element ORAI2, PIEZO1, ORC3 KMT2A 1144/4885CYP1B1 4690/4885CYP1A1 4009/4885
US-20190135730-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRONIC ELEMENT ORAI2, PIEZO1, ORC3 KMT2A 1144/4885CYP1B1 4690/4885CYP1A1 4009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.